Boehringer In­gel­heim ties the knot with Num­ab on new an­ti­bod­ies; Ca­balet­ta inks pact with Ar­ti­san

→ Switzer­land’s Num­ab Ther­a­peu­tics has added Boehringer In­gel­heim to its ros­ter of col­lab­o­ra­tors. And they will start with two projects …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.